Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (23468)	7/24/1998 7:58:00 AM
From: Henry Niman	Respond to of 32384

Mudcat, I believe that LGND was talking with several companies about a diabetes deal, and the WLA negotiations had become fairly advanced. I had heard that WLA did not want to give significant up front payments, and I see no mention of up front funds in the AGN press release. I had speculated on JNJ before it became clear that the LGND diabetes deal would keep AGN at arms length. The discussions with WLA happened last summer. The post that you referenced was well after LGND switch to another company (which of course was LLY).